<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" humanitarian="0" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>SE-0-SE-29-2013-6570-248-13040</iati-identifier>
  <reporting-org ref="SE-0" secondary-reporter="0" type="10">
   <narrative xml:lang="EN">Sweden</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="SV">Betydelsen av k&#xF6;nshormoner f&#xF6;r genital smitta fr&#xE5;n Kenyanska HIV-infekterade kvinnor</narrative>
   <narrative xml:lang="EN">The influence of female sex hormones on genital viral shedding in Kenyan HIV infected women</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">Hormonal contraceptive use and hormonal fluctuations during the menstrual cycle can increase genital viral load and thereby sexual transmission of HIV infection as demonstrated in epidemiological and experimental studies. The molecular mechanisms behind these findings are however poorly defined. We here aim to study how the human female genital tract is affected by these hormonal factors by assessing tissue samples and cervicovaginal secretions from cohorts of Swedish and Kenyan women. The genital samples will be defined by expression of junction proteins, distribution and density of HIV receptors, innate immune proteins and genital microflora by using immunohistochemistry, qPCR, proteomics and microbiomics. CD8+ T cells and other innate immune proteins and effector cells play a pivotal role in controlling HIV replication. We here also aim to investigate how these cells and immune activation/inflammation markers influence HIV infection and shedding at the local tissue site. Different CD8+ T cell phenotypes will be correlated to local viral load in both genital secretions and cervical tissue samples. By exploring some of the underlying mechanisms for a dysfunctional mucosal barrier and a disrupted mucosal immune response we hope to contribute to the development of topical compounds against viral transmission and to prescription of optimal contraceptive methods to HIV infected women.</narrative>
   <narrative xml:lang="SV">Sexuell &#xF6;verf&#xF6;ring av HIV-infektion fr&#xE5;n en smittad kvinna till en osmittad man p&#xE5;verkas av m&#xE5;nga olika faktorer. I kliniska och experimentella studier har man observerat att anv&#xE4;ndningen av vissa typer av preventivmedel och olika niv&#xE5;er av de kvinnliga k&#xF6;nshormonerna under menstruationscykeln kan &#xF6;ka smittorisken. De molekyl&#xE4;ra mekanismerna bakom dessa resultat &#xE4;r dock d&#xE5;ligt definierade. I detta projekt kommer vi att studera hur den kvinnliga genitala slemhinnebarri&#xE4;ren p&#xE5;verkas av hormonella faktorer. V&#xE4;vnadsprover och genitalsekret har samlats in fr&#xE5;n svenska och kenyanska studiepatienter och dessa kommer att analyseras f&#xF6;r kvaliteten p&#xE5; de skyddande epitelcellerna och f&#xF6;r olika immunologiska mark&#xF6;rer i slemhinnan. Den genitala bakteriefloran kan ocks&#xE5; ha betydelse f&#xF6;r HIV k&#xE4;nslighet och kommer d&#xE4;rf&#xF6;r att kartl&#xE4;ggas. Genom att utforska n&#xE5;gra av de underliggande mekanismerna f&#xF6;r en skadad barri&#xE4;r hoppas vi kunna bidra till den framtida utvecklingen av f&#xF6;rebyggande antivirala l&#xE4;kemedel och till en mindre riskfylld anv&#xE4;ndning av preventivmedel f&#xF6;r kvinnor som &#xE4;r HIV-infekterade.</narrative>
  </description>
  <participating-org ref="SE-0" role="1" type="10">
   <narrative xml:lang="EN">Sweden</narrative>
  </participating-org>
  <participating-org ref="SE-29" role="3" type="10">
   <narrative xml:lang="EN">The Swedish Research Council</narrative>
  </participating-org>
  <participating-org ref="51000" role="4" type="80">
   <narrative xml:lang="EN">University, college or other teaching institution, research institute or think-tank</narrative>
  </participating-org>
  <activity-status code="4"></activity-status>
  <activity-date iso-date="2014-01-01" type="1"></activity-date>
  <activity-date iso-date="2014-01-01" type="2"></activity-date>
  <activity-date iso-date="2016-12-31" type="3"></activity-date>
  <activity-date iso-date="2016-12-31" type="4"></activity-date>
  <contact-info>
   <organisation>
    <narrative xml:lang="EN">The Swedish Research Council</narrative>
   </organisation>
   <telephone>+46 8 546 44 000</telephone>
   <email>vetenskapsradet@vr.se</email>
   <website>www.vr.se</website>
   <mailing-address>
    <narrative xml:lang="EN">Box 1035, 101 38 Stockholm, Sweden</narrative>
   </mailing-address>
  </contact-info>
  <recipient-country code="KE" percentage="100">
   <narrative xml:lang="EN">Kenya</narrative>
  </recipient-country>
  <sector code="130" percentage="100" vocabulary="2">
   <narrative xml:lang="EN">Population Policies/Programmes &amp; Reproductive Health</narrative>
  </sector>
  <sector code="13040" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">STD control including HIV/AIDS</narrative>
  </sector>
  <policy-marker code="5" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Convention on Biological Diversity</narrative>
  </policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Convention to Combat Desertification</narrative>
  </policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Framework Convention on Climate Change - Adaptation</narrative>
  </policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Framework Convention on Climate Change - Mitigation</narrative>
  </policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid to Environment</narrative>
  </policy-marker>
  <policy-marker code="11" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Disability</narrative>
  </policy-marker>
  <policy-marker code="10" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Disaster Risk Reduction(DRR)</narrative>
  </policy-marker>
  <policy-marker code="1" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Gender Equality</narrative>
  </policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Participatory Development/Good Governance</narrative>
  </policy-marker>
  <policy-marker code="9" significance="2" vocabulary="1">
   <narrative xml:lang="EN">Reproductive, Maternal, Newborn and Child Health (RMNCH)</narrative>
  </policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Trade Development</narrative>
  </policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="D02" vocabulary="1"></default-aid-type>
  <default-tied-status code="4"></default-tied-status>
  <budget>
   <period-start iso-date="2014-01-01"></period-start>
   <period-end iso-date="2014-12-28"></period-end>
   <value currency="USD" value-date="2014-01-01">177116.2844939431</value>
  </budget>
  <budget>
   <period-start iso-date="2015-01-01"></period-start>
   <period-end iso-date="2015-12-28"></period-end>
   <value currency="USD" value-date="2015-01-01">111041.2489767834</value>
  </budget>
  <budget>
   <period-start iso-date="2016-01-01"></period-start>
   <period-end iso-date="2016-12-28"></period-end>
   <value currency="USD" value-date="2016-01-01">109390.5218255128</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2013-11-07"></transaction-date>
   <value currency="USD" value-date="2013-11-07">473960.5723760977</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2014-01-28"></transaction-date>
   <value currency="USD" value-date="2014-01-28">177116.2844939431</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2015-01-28"></transaction-date>
   <value currency="USD" value-date="2015-01-28">111041.2489767834</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-01-28"></transaction-date>
   <value currency="USD" value-date="2016-01-28">109390.5218255128</value>
  </transaction>
  <document-link format="APPLICATION/PDF" url="http://upload.openaid.se/document/ingen-myndighet-vald/generella-bidragsvillkor-2014.pdf">
   <title>
    <narrative xml:lang="SV">Generella bidragsvillkor 2014</narrative>
   </title>
   <category code="A04"></category>
  </document-link>
  <crs-add>
   <other-flags code="1" significance="1"></other-flags>
  </crs-add>
  <sida:contribution xmlns:sida="http://sida.se/ns/contribution#"></sida:contribution>
 </iati-activity>
</iati-activities>
